| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Neurology and the Endocrine Metabolism Unit of the Department of Medicine, University of Rochester Medical Center Rochester, New York 14642
Address requests for reprints to: Paul D. Woolf, M.D., The University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642.
The function of the pituitary-adrenal axis was studied in 23 acutely brain-injured, comatose patients (14 head trauma and 9 intracranial hemorrhage), who were treated with dexamethasone (16–64 mg/daily). Patients with normal intracranial pressure (ICP) and normal brain stem function (group 1) had decreased plasma cortisol levels (
5 µg/dl) within 36 h (mean ± SEM, 2.4 ± 0.3 µg/dl; t
, 18 h). In contrast, patients with elevated ICP (i.e. >20 mm Hg; midline shift, or compressed ventricles) and normal brain stem function (group 2) had persistently elevated cortisol concentrations (15.4 ± 2.6 µg/dl; P < 0.001). Superimposition of brain stem dysfunction resulted in generally low cortisol levels regardless of the presence (group 4; 3.9 ± 1.0 µg/dl; P < 0.001 compared to group 2) or absence (group 3; 2.1 ± 0.5 µg/dl) of elevated ICP. Plasma ACTH levels in 31 samples obtained before or during dexamethasone therapy in 14 patients irrespective of group were not elevated (45.6 ± 12.5 pg/ml); there was no correlation between plasma ACTH and cortisol levels. Despite elevated cortisol values in group 2, ACTH levels were low (22.4 ± 10.1 pg/ml). It is concluded that elevated ICP in the presence of normal brain stem function is a potent stimulus for adrenocortical activation which is not associated with elevated ACTH levels, and that the brain stem is involved in this response.
* This work was supported in part by funds from the NIH (NINCDS 13734 and AM-27303), and Contract DAMD 17-83-C-3142 from the U.S. Army.
Received June 13, 1983.
This article has been cited by other articles:
![]() |
L A Behan, J Phillips, C J Thompson, and A Agha Neuroendocrine disorders after traumatic brain injury J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tanriverdi, H. Senyurek, K. Unluhizarci, A. Selcuklu, F. F. Casanueva, and F. Kelestimur High Risk of Hypopituitarism after Traumatic Brain Injury: A Prospective Investigation of Anterior Pituitary Function in the Acute Phase and 12 Months after Trauma J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2105 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bernard, J. Outtrim, D. K. Menon, and B. F. Matta Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: clinical implications Br. J. Anaesth., January 1, 2006; 96(1): 72 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bondanelli, M. R. Ambrosio, M. C. Zatelli, L. De Marinis, and E. C d. Uberti Hypopituitarism after traumatic brain injury Eur. J. Endocrinol., May 1, 2005; 152(5): 679 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bone, M. Diver, A. Selby, A. Sharples, M. Addison, and P. Clayton Assessment of Adrenal Function in the Initial Phase of Meningococcal Disease Pediatrics, September 1, 2002; 110(3): 563 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chiolero, Y. Schutz, T. Lemarchand, J.-P. Felber, N. De Tribolet, J. Freeman, and E. Jequier Hormonal and Metabolic Changes following Severe Head Injury or Noncranial Injury JPEN J Parenter Enteral Nutr, January 1, 1989; 13(1): 5 - 12. [Abstract] [PDF] |
||||
![]() |
B. Chernow, H. R. Alexander, R. C. Smallridge, W. R. Thompson, D. Cook, D. Beardsley, M. P. Fink, C. R. Lake, and J. R. Fletcher Hormonal Responses to Graded Surgical Stress Arch Intern Med, July 1, 1987; 147(7): 1273 - 1278. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |